Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Pomalidomide
Drug ID BADD_D01798
Description Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013.
Indications and Usage Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Marketing Status approved
ATC Code L04AX06
DrugBank ID DB08910
KEGG ID D08976
MeSH ID C467566
PubChem ID 134780
TTD Drug ID D0A3ZU
NDC Product Code 65015-893; 17337-0068; 63069-404; 68554-0092; 70225-1106; 59572-501; 59572-502; 55111-989; 68554-0091; 82245-0108; 63069-402; 42973-232; 54893-0038; 59572-503; 59572-504; 63069-403
UNII D2UX06XLB5
Synonyms pomalidomide | CC-4047 | CC 4047 | CC4047 | Imnovid | Pomalyst | actimid
Chemical Information
Molecular Formula C13H11N3O4
CAS Registry Number 19171-19-8
SMILES C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.0010.030043%
Abdominal pain07.01.05.002--
Acrochordon23.10.01.005; 16.26.01.0050.000820%Not Available
Acute leukaemia16.01.02.001; 01.10.02.0010.000241%Not Available
Acute respiratory failure14.01.04.004; 22.02.06.0010.003134%Not Available
Adenocarcinoma16.16.01.0040.000241%Not Available
Adrenal disorder05.01.03.0010.000241%Not Available
Ageusia17.02.07.001; 07.14.03.0030.013960%Not Available
Alanine aminotransferase increased13.03.04.005--
Altered state of consciousness19.07.01.003; 17.02.04.001--Not Available
Amnesia19.20.01.001; 17.03.02.0010.024063%
Amyloidosis10.02.05.0010.001326%Not Available
Anaemia01.03.02.001--
Angina pectoris24.04.04.002; 02.02.02.002--
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.009--Not Available
Anosmia22.04.03.006; 17.04.04.0010.002580%
Anxiety19.06.02.002--
Aortic valve stenosis02.07.03.0040.000241%Not Available
Arthralgia15.01.02.001--
Arthritis15.01.01.0010.014129%
Arthropathy15.01.01.0030.014804%Not Available
Aspartate aminotransferase increased13.03.04.011--
Asthenia08.01.01.0010.160943%Not Available
Asthma22.03.01.002; 10.01.03.0100.008222%Not Available
Atrial fibrillation02.03.03.0020.024039%
Auditory disorder04.02.03.0020.000940%Not Available
Azotaemia20.01.01.0010.000362%Not Available
Back disorder15.03.05.0030.008559%Not Available
Back pain15.03.04.0050.094299%
Bacteraemia11.01.11.001--
The 1th Page    1 2 3 4 5    Next   Last    Total 16 Pages